| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0075 | 0.9 |